CYCN
HEALTHCARECyclerion Therapeutics Inc
$3.24+0.09 (+2.86%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CYCN Today?
No stock-specific AI insight has been generated for CYCN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.03$8.48
$3.24
Fundamentals
Market Cap$14M
P/E Ratio—
EPS$-1.11
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-1.7%
Debt / Equity—
Trading
Volume69K
Avg Volume (10D)—
Shares Outstanding4.3M
CYCN News
14 articles- Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s PipelineYahoo Finance·Apr 20, 2026
- Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc.·Apr 7, 2026
- Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?Barchart·Apr 2, 2026
- Top Midday GainersYahoo Finance·Apr 1, 2026
- Cyclerion Therapeutics and Korsana Biosciences Announce Merger AgreementYahoo Finance·Apr 1, 2026
- CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26Yahoo Finance·Feb 23, 2026
- Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory BoardYahoo Finance·Feb 17, 2026
- CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics…Yahoo Finance·Feb 2, 2026
- BC-Most Active StocksYahoo Finance·Jan 6, 2026
- Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant DepressionYahoo Finance·Jan 5, 2026
- Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio DealYahoo Finance·Dec 1, 2025
- Insider Stock Buying Reaches US$525.0k On Cyclerion TherapeuticsYahoo Finance·Nov 11, 2025
- EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning NetworkYahoo Finance·Nov 10, 2025
- Cyclerion Announces Transformational Relaunch as a Neuropsychiatric CompanyYahoo Finance·Sep 23, 2025
All 14 articles loaded
Price Data
Open$3.22
Previous Close$3.15
Day High$3.31
Day Low$3.20
52 Week High$8.48
52 Week Low$1.03
52-Week Range
$1.03$8.48
$3.24
Fundamentals
Market Cap$14M
P/E Ratio—
EPS$-1.11
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-1.7%
Debt / Equity—
Trading
Volume69K
Avg Volume (10D)—
Shares Outstanding4.3M
About Cyclerion Therapeutics Inc
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of drugs for serious diseases of the central nervous system (CNS). The company is headquartered in Cambridge, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—